RebrAIn is excited to announce that its co-founders, Prof. Emmanuel Cuny, MD, and Prof. Nejib Zemzemi, PhD, will be presenting groundbreaking research on VIM targeting techniques at the upcoming World Society for Stereotactic and Functional Neurosurgery (WSSFN) biennial meeting. The conference, taking place in Chicago, IL, on September 5, 2024, brings together the world’s leading experts in neurosurgery to share the latest advancements in the field.
The presentation, titled “VIM Lesions in Radiosurgery and Focused Ultrasound: Assessment of the Accuracy of Two Targeting Models Based on Machine Learning,” will delve into the complexities of targeting the ventro-intermediate nucleus (VIM) for lesioning techniques such as MR-guided Focused Ultrasound (MRgFUS) and Radiosurgery. This cutting-edge research showcases RebrAIn’s innovative use of AI-driven models to enhance precision in neurosurgical procedures, offering new hope for patients with conditions like Essential Tremor.
“Our research is focused on overcoming the challenges of accurate VIM targeting, a critical component in advancing treatments for neurological disorders,” said Prof. Emmanuel Cuny. “By integrating machine learning with clinical data, we are developing tools to optimize the targeting during neurosurgical procedures, with the objective to enhance patient outcomes.”
The WSSFN biennial meeting is a premier event for neurosurgeons and researchers worldwide, providing a platform to discuss the latest innovations and share knowledge that shapes the future of the field. RebrAIn’s presentation will highlight the company’s commitment to advancing brain health through the application of artificial intelligence in neurosurgery.
Attendees are encouraged to join the presentation to gain insights into RebrAIn’s novel approaches and explore the potential of AI in improving neurosurgical techniques. “We believe our findings will stimulate valuable discussions and foster collaborations that drive the next generation of neurosurgical care,” added Prof. Zemzemi.
